相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Barium Titanate Nanoparticles Sensitise Treatment-Resistant Breast Cancer Cells to the Antitumor Action of Tumour-Treating Fields
Yi Na Yoon et al.
SCIENTIFIC REPORTS (2020)
Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
Francesca A. Carrieri et al.
FRONTIERS IN ONCOLOGY (2020)
Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial
Matthew T. Ballo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Genotoxic effects of intermediate frequency magnetic fields on blood leukocytes in vitro
Annamaria Brech et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2019)
Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
Vikram S. Soni et al.
CANCER IMAGING (2019)
Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
Yunhui Jo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tumor Treating Fields Elicit a Conditional Vulnerability in Non-Small Cell Lung Cancer Cell Lines Through the Down-Regulation of Key DNA Repair and Replication Stress Pathways that When Targeted with Chemoradiation Results in Synergistic Cell Killing
N. K. Karanam et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
Anna Shteingauz et al.
CELL DEATH & DISEASE (2018)
Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity
Weiwei Shi et al.
CELL REPORTS (2018)
Tumor treating fields increases membrane permeability in glioblastoma cells
Edwin Chang et al.
CELL DEATH DISCOVERY (2018)
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Elijah J. Mun et al.
CLINICAL CANCER RESEARCH (2018)
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Jay-Jiguang Zhu et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: A too simplistic explanation that does not take into account the nanoparticle protein corona
Valerie Forest et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines
Narasimha Kumar Karanam et al.
CELL DEATH & DISEASE (2017)
Of Fields and Phantoms The importance of virtual humans in optimizing cancer treatment with tumor treating fields
Ze'ev Bomzon et al.
IEEE PULSE (2017)
INNOVATE: A phase II study of TTFields (200 kHz) concomitant with weekly paclitaxel for recurrent ovarian cancer-Updated safety and efficacy results.
Ignace Vergote et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma
James Coventon
JOURNAL OF BONE ONCOLOGY (2017)
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo
Tali Voloshin et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The role for autophagy in cancer
Eileen White
JOURNAL OF CLINICAL INVESTIGATION (2015)
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
Moshe Giladi et al.
SCIENTIFIC REPORTS (2015)
Early Exposure to Intermediate-Frequency Magnetic Fields Alters Brain Biomarkers without Histopathological Changes in Adult Mice
Tin-Tin Win-Shwe et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2015)
Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy
Hojjat Naderi-Meshkin et al.
CELL BIOLOGY INTERNATIONAL (2015)
Adaptive response in mammalian cells exposed to non-ionizing radiofrequency fields: A review and gaps in knowledge
Vijayalaxmi et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2014)
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Lauren M. Zasadil et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Alternating Electric Fields (Tumor-Treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-Small Cell Lung Cancer Both In Vitro and In Vivo
Moshe Giladi et al.
SEMINARS IN ONCOLOGY (2014)
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system
Scott G. Turner et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
Miklos Pless et al.
LUNG CANCER (2013)
In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations
Christoph E. Albers et al.
NANOTOXICOLOGY (2013)
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Eleonore Froehlich
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing
Eleonore Froehlich et al.
NANOTOXICOLOGY (2012)
Uptake and intracellular localization of submicron and nano-sized SiO2 particles in HeLa cells
Marco Al-Rawi et al.
ARCHIVES OF TOXICOLOGY (2011)
Induction of adaptive response in human blood lymphocytes exposed to 900 MHz radiofrequency fields: Influence of cell cycle
Anna Sannino et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
Rosa S. Schneiderman et al.
BMC CANCER (2010)
Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro
Anders Ullen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
The many roles of NOX2 NADPH oxidase-derived ROS in immunity
Grace Y. Lam et al.
SEMINARS IN IMMUNOPATHOLOGY (2010)
Adaptive response - Some underlying mechanisms and open questions
Evgeniya G. Dimova et al.
GENETICS AND MOLECULAR BIOLOGY (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Predictive factors for response to docetaxel in human breast cancers
Shinzaburo Noguchi
CANCER SCIENCE (2006)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
分享论文
